TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Novo Nordisk Pharma Operations A/S
Closing information (x1000 DKK)
Closing information | 2021/12 | 2020/12 | 2019/12 |
Turnover |
98,630
|
79,197
|
81,042 |
Earnings before taxes |
4,398
|
3,733
|
3,869 |
Total assets |
70,860
|
54,676
|
55,917 |
Current assets |
59,841
|
48,529
|
44,238 |
Current liabilities |
42,493
|
36,801
|
38,246 |
Equity capital |
20,538
|
17,383
|
14,369 |
- share capital |
500
![]() |
500
![]() |
500 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Solvency |
29.0%
|
31.8%
|
25.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
4.5%
|
4.7%
|
4.8% |
Return on assets (ROA) | |||
Current ratio |
140.8%
|
131.9%
|
115.7% |
Return on equity (ROE) |
21.4%
|
21.5%
|
26.9% |
Change turnover |
19,433
|
-1,845
|
19,681 |
Change turnover % |
25%
|
-2%
|
32% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.